Sunshine Biopharma (SBFM) Interest Coverage Ratio Growth (3y) (2015 - 2024)
Sunshine Biopharma (SBFM) Interest Coverage Ratio Growth (3y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 4.39% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 74.02% |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | - |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | - |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 42.49% |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | -3.66% |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 121.93% |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 46.64% |
| 10 | Sunshine Biopharma | 11.09 Mn | 4.17 Mn | 2.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -215.14% |
| Jun 30, 2024 | -1,276.13% |
| Mar 31, 2024 | -2.29% |
| Dec 31, 2023 | -129.63% |
| Sep 30, 2023 | -87.99% |
| Jun 30, 2023 | -285.61% |
| Mar 31, 2023 | -168.32% |
| Dec 31, 2022 | -334.87% |
| Sep 30, 2022 | -4,805.47% |
| Mar 31, 2022 | -230.28% |
| Dec 31, 2021 | -13.54% |
| Sep 30, 2021 | 9.00% |
| Jun 30, 2021 | 56.54% |
| Mar 31, 2021 | -126.48% |
| Dec 31, 2020 | -5.61% |
| Sep 30, 2020 | 9.80% |
| Jun 30, 2020 | 52.39% |
| Mar 31, 2020 | 42.17% |
| Dec 31, 2019 | 43.54% |
| Sep 30, 2019 | 8.71% |